Fred E. Cohen, Director at Genomic Health, holds 143.16K shares in CareDx (Ticker: CDNA), holds 49.45K shares in Intellia Therapeutics (Ticker: NTLA), holds 22.69K shares in Progyny (Ticker: PGNY).
What is the percentage of profitable transactions made by Fred E. Cohen?
The percentage of profitable transactions made by Fred E. Cohen is 0%.
What is the average return per transaction made by Fred E. Cohen?
The average return per transaction made by Fred E. Cohen is -37.80%.
What stocks does Fred E. Cohen hold?
Fred E. Cohen holds: GHDX, NTLA, URGN, PGNY, KYTX, BCRX, CDNA, FPRX, TNDM, VCYT, ROKA, IQV stocks.
What was Fred E. Cohen’s latest transaction?
Fred E. Cohen latest transaction was an Uninformative Buy of ―.
What was Fred E. Cohen's most profitable transaction?
Fred E. Cohen’s most profitable transaction was an Informative Buy of BCRX stock on January 9, 2015. The return on the trade was -30.50%.
What is Fred E. Cohen's role in Genomic Health?
Fred E. Cohen's role in Genomic Health is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.